LIFE SCIENCES CASE STUDY
Biomedical R&D Consultant, Implantable Device Experience
Standard markets would have declined this on occupation alone, so we took it straight to our panel of specialist life sciences underwriters. We placed combined PI and PL with an underwriter that understood the work.
THE SITUATION
A specialist biomedical engineering consultant approached us to place cover for their sole-trader R&D advisory business. The consultant has extensive prior senior experience inside the implantable medical device manufacturing sector and runs their advisory work on a solo basis.
The work is narrow and highly technical. They provide biocompatibility and materials advice used in the design and development of implantable devices. This is exactly the kind of advice that standard insurers struggle to price, because the downstream exposure (an implantable device ultimately used in a patient) sits at the far end of the risk curve.
Professional Indemnity combined with Public Liability was the sensible structure, but from the outset we knew this wasn't going to be a tick-and-flick placement.
OUR APPROACH
The issue here is never really about the individual consultant. It's about how the occupation reads in an underwriter's system. "Implantable medical device consulting" will trigger an automatic referral or decline in most standard markets, regardless of who is doing the work.
We built the submission around the right framing from day one, focusing on:
- The client's depth of experience inside regulated Australian device manufacturing
- The advisory nature of the work (R&D guidance, not design sign-off or regulatory certification)
- The controls around documentation, scope of work and client selection
Standard markets would have declined the occupation outright, so we took the risk directly to our panel of specialist life sciences underwriters, who understood the work and provided terms.
THE CHALLENGES
The first challenge was the occupation itself. "Implantable medical device" is one of the more difficult occupation descriptions to place in the Australian market, so we knew a few declines were likely before landing with the right underwriter.
The second challenge was limit adequacy. A $1M Professional Indemnity limit is the floor for this type of work, and the client wanted Public Liability sitting above it to respond to any physical exposure at client sites. Not every specialist market will bind both layers in one placement for a sole trader.
The third was budget. The client is a sole operator with realistic turnover expectations. A premium that consumed a meaningful slice of annual revenue would have been a dealbreaker.
THE OUTCOME
We placed combined Professional Indemnity ($1M) and Public Liability ($5M) cover through a specialist underwriter at an annual premium of around $1,900.
This sits comfortably inside a realistic budget for a sole-trader biomedical consultancy, and demonstrates why market access matters for hard-to-place occupations in life sciences.
The broader lesson for anyone working in biomedical R&D: a decline or two on occupation doesn't mean you're uninsurable. It usually means the submission needs to reach a specialist market. The specialist Professional Indemnity and Public Liability markets are there. Reaching them is the broker's job.
This is the kind of placement we built our life sciences insurance capability around.
Put this placement in context
More Case Studies
All case studiesScientific & Data Consultancy, Metro Brisbane
A sole-trader scientific and data consultant supporting medical research teams in Australia, the US, Germany and South Africa. PI placed through a specialist market at around $900.
Read case study Life SciencesMaternity Therapeutic Device Hire Business
A specialist maternity support business hiring low-voltage therapeutic devices to expectant clients. PL and Product Liability placed after multiple standard insurer declines.
Read case study Life SciencesEarly-Stage Australian Baby Skincare Brand
A new Australian AICIS-registered baby skincare brand with overseas manufacturing. Product Liability placed through a specialist market after all standard markets declined.
Read case studyGot a Life Sciences Risk That's Been Declined?
A few declines doesn't mean you're uninsurable. It usually means the submission hasn't reached the right market yet. Talk to our team about how we place life sciences, biotech, medical device and consumer chemical risks.